{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:00:43Z","timestamp":1780063243721,"version":"3.54.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T00:00:00Z","timestamp":1547596800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Anna-Greta Crafoord Foundation"},{"name":"Kock Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1093\/rheumatology\/key427","type":"journal-article","created":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T23:17:49Z","timestamp":1544483869000},"page":"1176-1187","source":"Crossref","is-referenced-by-count":26,"title":["Elevated faecal calprotectin is linked to worse disease status in axial spondyloarthritis: results from the SPARTAKUS cohort"],"prefix":"10.1093","volume":"58","author":[{"given":"Tor","family":"Olofsson","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund"},{"name":"Department of Rheumatology, Sk\u00e5ne University Hospital, Lund"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Lindqvist","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund"},{"name":"Department of Rheumatology, Sk\u00e5ne University Hospital, Lund"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Mogard","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund"},{"name":"Department of Rheumatology, Sk\u00e5ne University Hospital, Lund"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristofer","family":"Andr\u00e9asson","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund"},{"name":"Department of Rheumatology, Sk\u00e5ne University Hospital, Lund"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Marsal","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Lund, Gastroenterology, Lund University, Lund"},{"name":"Department of Gastroenterology, Sk\u00e5ne University Hospital, Lund"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Geijer","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Lund, Diagnostic Radiology, Lund University, Lund"},{"name":"Department of Radiology, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Erik","family":"Kristensen","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund"},{"name":"Department of Rheumatology, The Parker Institute, Copenhagen University Hospital, Frederiksberg and Bispebjerg, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4915-2924","authenticated-orcid":false,"given":"Johan K","family":"Wallman","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund"},{"name":"Department of Rheumatology, Sk\u00e5ne University Hospital, Lund"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,1,15]]},"reference":[{"key":"2019062109401398400_key427-B1","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1053\/gast.1996.v110.pm8964393","article-title":"Long-term evolution of gut inflammation in patients with spondyloarthropathy","volume":"110","author":"De Vos","year":"1996","journal-title":"Gastroenterology"},{"key":"2019062109401398400_key427-B2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/annrheumdis-2013-203582","article-title":"Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis","volume":"74","author":"Stolwijk","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2019062109401398400_key427-B3","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/rheumatology\/ket164","article-title":"Percentage of patients with spondyloarthritis in patients referred because of chronic back pain and performance of classification criteria: experience from the Spondyloarthritis Caught Early (SPACE) cohort","volume":"52","author":"van den Berg","year":"2013","journal-title":"Rheumatology"},{"key":"2019062109401398400_key427-B4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jbspin.2015.02.006","article-title":"Clinical presentation of patients suffering from recent onset chronic inflammatory back pain suggestive of spondyloarthritis: the DESIR cohort","volume":"82","author":"Dougados","year":"2015","journal-title":"Joint Bone Spine"},{"key":"2019062109401398400_key427-B5","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/art.22812","article-title":"A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland","volume":"56","author":"Thjodleifsson","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2019062109401398400_key427-B6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nrrheum.2012.41","article-title":"Genetics of spondyloarthritis\u2013beyond the MHC","volume":"8","author":"Reveille","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"2019062109401398400_key427-B7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0016-5085(89)91557-6","article-title":"Ileocolonoscopy in seronegative spondylarthropathy","volume":"96","author":"De Vos","year":"1989","journal-title":"Gastroenterology"},{"key":"2019062109401398400_key427-B8","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/annrheumdis-2013-203854","article-title":"Degree of bone marrow oedema in sacroiliac joints of patients with axial spondyloarthritis is linked to gut inflammation and male sex: results from the GIANT cohort","volume":"73","author":"Van Praet","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2019062109401398400_key427-B9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"2019062109401398400_key427-B10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2019062109401398400_key427-B11","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/acr.21994","article-title":"Prevalence of axial spondyloarthritis in United States rheumatology practices: assessment of SpondyloArthritis International Society criteria versus rheumatology expert clinical diagnosis","volume":"65","author":"Strand","year":"2013","journal-title":"Arthritis Care Res"},{"key":"2019062109401398400_key427-B12","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1136\/annrheumdis-2017-211596","article-title":"Sacroiliac radiographic progression in recent onset axial spondyloarthritis: the 5-year data of the DESIR cohort","volume":"76","author":"Dougados","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2019062109401398400_key427-B13","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/ard.2010.145995","article-title":"Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis","volume":"70","author":"Poddubnyy","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2019062109401398400_key427-B14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/BOR.0000000000000071","article-title":"Similarities and differences between nonradiographic and radiographic axial spondyloarthritis: a clinical, epidemiological and therapeutic assessment","volume":"26","author":"Poddubnyy","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"2019062109401398400_key427-B15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/00365521.2011.648953","article-title":"Calprotectin in ankylosing spondylitis\u2014frequently elevated in feces, but normal in serum","volume":"47","author":"Klingberg","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"2019062109401398400_key427-B16","doi-asserted-by":"crossref","first-page":"R261","DOI":"10.1186\/ar4106","article-title":"Markers of intestinal inflammation in patients with ankylosing spondylitis: a pilot study","volume":"14","author":"Matzkies","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"2019062109401398400_key427-B17","first-page":"71","article-title":"Fecal calprotectin is associated with disease activity in patients with ankylosing spondylitis","volume":"16","author":"Duran","year":"2016","journal-title":"Bosn J Basic Med Sci"},{"key":"2019062109401398400_key427-B18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13075-017-1223-2","article-title":"A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis","volume":"19","author":"Klingberg","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2019062109401398400_key427-B19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/03009742.2017.1299216","article-title":"Faecal calprotectin detects subclinical bowel inflammation and may predict treatment response in spondyloarthritis","volume":"47","author":"\u00d8stg\u00e5rd","year":"2018","journal-title":"Scand J Rheumatol"},{"key":"2019062109401398400_key427-B20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.autrev.2014.01.029","article-title":"Diagnosis and classification of Crohn\u2019s disease","volume":"13","author":"Laass","year":"2014","journal-title":"Autoimmun Rev"},{"key":"2019062109401398400_key427-B21","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1053\/gast.2001.22122","article-title":"Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics","volume":"120","author":"Shanahan","year":"2001","journal-title":"Gastroenterology"},{"key":"2019062109401398400_key427-B22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/rheumatology\/kem324","article-title":"Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthropathies: a reassessment","volume":"47","author":"Aydin","year":"2008","journal-title":"Rheumatology"},{"key":"2019062109401398400_key427-B23","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00296-010-1722-9","article-title":"Anti-Saccharomyces cerevisiae (ASCA) and anti-endomysial antibodies in spondyloarthritis","volume":"32","author":"Andretta","year":"2012","journal-title":"Rheumatol Int"},{"key":"2019062109401398400_key427-B24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jbspin.2015.10.011","article-title":"Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthritis: prevalence and associated phenotype","volume":"83","author":"Maillet","year":"2016","journal-title":"Joint Bone Spine"},{"key":"2019062109401398400_key427-B25","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","article-title":"The functional gastrointestinal disorders and the Rome III process","volume":"130","author":"Drossman","year":"2006","journal-title":"Gastroenterology"},{"key":"2019062109401398400_key427-B26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/ard.2010.133488","article-title":"ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials\/epidemiological studies in axial spondyloarthritis","volume":"70","author":"Dougados","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2019062109401398400_key427-B27","first-page":"1491","article-title":"Macroscopic and microscopic gut lesions in seronegative spondyloarthropathies","volume":"17","author":"Simenon","year":"1990","journal-title":"J Rheumatol"},{"key":"2019062109401398400_key427-B28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/art.1780370105","article-title":"High frequency of silent inflammatory bowel disease in spondylarthropathy","volume":"37","author":"Leirisalo-Repo","year":"1994","journal-title":"Arthritis Rheum"},{"key":"2019062109401398400_key427-B29","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/annrheumdis-2012-202135","article-title":"Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model","volume":"72","author":"Van Praet","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2019062109401398400_key427-B30","first-page":"2279","article-title":"The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint","volume":"22","author":"Mielants","year":"1995","journal-title":"J Rheumatol"},{"key":"2019062109401398400_key427-B31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","article-title":"Immunopathogenesis of IBD: current state of the art","volume":"13","author":"de Souza","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2019062109401398400_key427-B32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/BOR.0000000000000506","article-title":"Fecal transplants in spondyloarthritis and uveitis: ready for a clinical trial?","volume":"30","author":"Choi","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"2019062109401398400_key427-B33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/BOR.0000000000000299","article-title":"The interaction between host genetics and the microbiome in the pathogenesis of spondyloarthropathies","volume":"28","author":"Asquith","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"2019062109401398400_key427-B34","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1136\/annrheumdis-2015-208025","article-title":"Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis","volume":"75","author":"Cypers","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2019062109401398400_key427-B35","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.berh.2014.10.018","article-title":"The role of the gut and microbes in the pathogenesis of spondyloarthritis","volume":"28","author":"Asquith","year":"2014","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2019062109401398400_key427-B36","doi-asserted-by":"crossref","DOI":"10.3310\/hta17550","article-title":"Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation","volume":"17","author":"Waugh","year":"2013","journal-title":"Health Technol Assess"},{"key":"2019062109401398400_key427-B37","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/00365521.2016.1256424","article-title":"Clinical implications of assay specific differences in f-calprotectin when monitoring inflammatory bowel disease activity over time","volume":"52","author":"Amcoff","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"2019062109401398400_key427-B38","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/ard.62.5.455","article-title":"Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy","volume":"62","author":"Hoffman","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"2019062109401398400_key427-B39","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000080081","article-title":"Inflammatory bowel disease\u2013specific autoantibodies in HLA-B27\u2013associated spondyloarthropathies: increased prevalence of ASCA and pANCA","volume":"70","author":"Torok","year":"2004","journal-title":"Digestion"},{"key":"2019062109401398400_key427-B40","first-page":"920","article-title":"Antibodies to tissue transglutaminase and Saccharomyces cerevisiae in ankylosing spondylitis and psoriatic arthritis","volume":"31","author":"Riente","year":"2004","journal-title":"J Rheumatol"},{"key":"2019062109401398400_key427-B41","doi-asserted-by":"crossref","first-page":"R177","DOI":"10.1186\/ar2866","article-title":"Inflammatory bowel disease serologies in ankylosing spondylitis patients: a pilot study","volume":"11","author":"Mundwiler","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"2019062109401398400_key427-B42","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.3899\/jrheum.100269","article-title":"pANCA, ASCA, and OmpC antibodies in patients with ankylosing spondylitis without inflammatory bowel disease","volume":"37","author":"de Vries","year":"2010","journal-title":"J Rheumatol"},{"key":"2019062109401398400_key427-B43","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar4350","article-title":"Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study","volume":"15","author":"Wallis","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2019062109401398400_key427-B44","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00296-014-3088-x","article-title":"An investigation into the relationship between anti-Helicobacter pylori and anti-Saccharomyces cerevisiae antibodies in patients with axial spondyloarthritis and Crohn disease","volume":"35","author":"Rodrigues","year":"2015","journal-title":"Rheumatol Int"},{"key":"2019062109401398400_key427-B45","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s13075-015-0897-6","article-title":"Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients\u2014baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice","volume":"17","author":"Wallman","year":"2015","journal-title":"Arthritis Res Ther"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/58\/7\/1176\/28852893\/key427.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T09:40:28Z","timestamp":1561110028000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/58\/7\/1176\/5289598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,15]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,1,15]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/key427","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2019,1,15]]}}}